Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Tumor Immunotherapy01:27

Tumor Immunotherapy

567
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
567
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

62
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
62
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

5.8K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.8K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.8K
Cancer Vaccines01:30

Cancer Vaccines

419
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
419
Cancer Therapies02:49

Cancer Therapies

7.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Tunable orbital angular momentum mode filter based on optical geometric transformation.

Optics letters·2014
Same author

Various applications of TALEN- and CRISPR/Cas9-mediated homologous recombination to modify the Drosophila genome.

Biology open·2014
Same author

Esophageal cancer-selective expression of TRAIL mediated by MREs of miR-143 and miR-122.

Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine·2014
Same author

Application of traditional Chinese medicine preparation in targeting drug delivery system.

Drug delivery·2014
Same author

Engineering fluorescent poly(dopamine) capsules.

Langmuir : the ACS journal of surfaces and colloids·2014
Same author

100 Tbit/s free-space data link enabled by three-dimensional multiplexing of orbital angular momentum, polarization, and wavelength.

Optics letters·2014

相关实验视频

Updated: Jul 23, 2025

Monitoring the Cancer-Immunity Cycle and Exploring Tumor Microenvironment Dynamics
12:19

Monitoring the Cancer-Immunity Cycle and Exploring Tumor Microenvironment Dynamics

Published on: June 7, 2024

1.1K

微生物代码和癌症免疫治疗结果.

Yan Yan1

  • 1CAS Key Laboratory of Molecular Virology and Immunology, Chinese Academy of Sciences (CAS), Shanghai 200025, China.

Cell host & microbe
|July 13, 2023
PubMed
概括

肠道微生物组显著影响癌症免疫治疗的有效性. 研究人员在治疗前确定了特定的微生物模式,可以预测患者的反应,为个性化医学提供了新的策略.

科学领域:

  • 免疫学 免疫学 免疫学
  • 微生物学 微生物学
  • 在瘤学瘤学.

背景情况:

  • 肠道微生物组在免疫反应中的作用,特别是在癌症免疫治疗中,仍然在很大程度上未被描述.
  • 了解微生物的影响对于优化癌症治疗结果至关重要.

研究的目的:

  • 在癌症免疫疗法之前调查肠道微生物组的配置.
  • 确定抗生素掩盖的微生物特征如何影响免疫疗法的疗效.

主要方法:

  • 在癌症免疫治疗前对微生物组合的分析.
  • 评估与治疗反应相关的微生物特征.

主要成果:

  • 确定了与免疫疗法的有效性相关的特定微生物配置.
  • 证明了以前隐藏的微生物特征对治疗结果的影响.

结论:

  • 肠道微生物组在调节癌症治疗的免疫反应方面发挥着至关重要的作用.
  • 微生物签名可以作为免疫治疗成功的预测生物标志物.
  • 这项研究为开发在瘤学中基于微生物组的临床策略提供了框架.

更多相关视频

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells
09:01

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells

Published on: March 7, 2025

446
Author Spotlight: Unlocking Insights into the Immune Cell Landscape of Tumors
06:32

Author Spotlight: Unlocking Insights into the Immune Cell Landscape of Tumors

Published on: August 18, 2023

2.1K

相关实验视频

Last Updated: Jul 23, 2025

Monitoring the Cancer-Immunity Cycle and Exploring Tumor Microenvironment Dynamics
12:19

Monitoring the Cancer-Immunity Cycle and Exploring Tumor Microenvironment Dynamics

Published on: June 7, 2024

1.1K
Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells
09:01

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells

Published on: March 7, 2025

446
Author Spotlight: Unlocking Insights into the Immune Cell Landscape of Tumors
06:32

Author Spotlight: Unlocking Insights into the Immune Cell Landscape of Tumors

Published on: August 18, 2023

2.1K